BTMDW
Biote Corp.
A maker of bioidentical hormone replacement therapy products, Biote Corp. trains and certifies doctors to implant tiny, grain-of-rice-sized hormone pellets under the skin, and supplies the kits, software, and marketing support their practices need. The company was founded in 2012 by OB/GYN Gary Donovitz, who turned to hormone therapy after seeing it transform a patient's life, and went public in 2022. Its name is a mashup of "bioidentical" and "testosterone."
WARRANTUnderlying: BTMDCUSIP: 090683111HealthcareUS2 holders
Class A Common Stock
Total Value
$1.7K
Total Shares
4.0K
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
